We only have this paper's title and publication details.
Read it at the sourceAre BCAAs a biomarker, causal agent, or both in cardiometabolic disease?
No takes yet. Share an insight, caveat, or question.
White et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: